Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
Servier
Alliance for Clinical Trials in Oncology
Mayo Clinic
Massive Bio, Inc.
Stanford University
Cancer Support Community, Research and Training Institute, Philadelphia